C Program | List of Frontiers open access articles

Original Research

Published on 28 Feb 2025

T cell receptor usage and epitope specificity amongst CD8+ and CD4+ SARS-CoV-2-specific T cells

in Viral Immunology

Ulrik Fahnøe
Shan Feng
Alexander P. Underwood
Kivin Jacobsen
Amir Ameri
Thomas H. Blicher
Christina S. Sølund
Brad R. Rosenberg
Liselotte Brix
Nina Weis

Frontiers in Immunology

doi 10.3389/fimmu.2025.1510436

3,516 views
3 citations

Original Research

Accepted on 11 Feb 2026

GFTrans: An On-the-fly Static Analysis Framework for Code Performance Profiling

in Data Mining and Management

Jie Li
Yunbao Wen
Jingxin Liu
Biqing Zeng
Seyedali Mirjalili

Frontiers in Big Data

105 views

Review

Published on 27 Sep 2018

Hypervariable Region 1 in Envelope Protein 2 of Hepatitis C Virus: A Linchpin in Neutralizing Antibody Evasion and Viral Entry

in Vaccines and Molecular Therapeutics

Jannick Prentoe
Jens Bukh

Frontiers in Immunology

doi 10.3389/fimmu.2018.02146

7,983 views
55 citations

Original Research

Published on 20 Mar 2024

Neutralizing antibody and CD8+ T cell responses following BA.4/5 bivalent COVID-19 booster vaccination in adults with and without prior exposure to SARS-CoV-2

in Vaccines and Molecular Therapeutics

Alexander P. Underwood
Christina Sølund
Kivin Jacobsen
Alekxander Binderup
Carlota Fernandez-Antunez
Lotte S. Mikkelsen
Dilek Inekci
Signe Lysemose Villadsen
Jose A. S. Castruita
Mette Pinholt

Frontiers in Immunology

doi 10.3389/fimmu.2024.1353353

3,923 views
9 citations

Systematic Review

Published on 01 Sep 2025

Cure of chronic hepatitis C virus infection after DAA treatment only partially restores the functional capacity of exhausted T cell subsets: a systematic review

in Viral Immunology

Ása Didriksen Apol
Christina Sølund
Caroline Vinten
Alexander P. Underwood
Jens Bukh
Nina Weis

Frontiers in Immunology

doi 10.3389/fimmu.2025.1546915

3,151 views
2 citations

Brief Research Report

Published on 23 Jan 2023

SARS-CoV-2 spike HexaPro formulated in aluminium hydroxide and administered in an accelerated vaccination schedule partially protects Syrian Hamsters against viral challenge despite low neutralizing antibody responses

in Vaccines and Molecular Therapeutics

Dennis Christensen
Charlotta Polacek
Daniel J. Sheward
Leo Hanke
Gerald McInerney
Ben Murrell
Katrine Top Hartmann
Henrik Elvang Jensen
Julie Zimmermann
Gregers Jungersen

Frontiers in Immunology

doi 10.3389/fimmu.2023.941281

5,082 views
7 citations

Original Research

Published on 25 Jun 2021

In vitro Characterization of Fitness and Convalescent Antibody Neutralization of SARS-CoV-2 Cluster 5 Variant Emerging in Mink at Danish Farms

in Virology

Ria Lassaunière
Jannik Fonager
Morten Rasmussen
Anders Frische
Charlotta Polacek
Thomas Bruun Rasmussen
Louise Lohse
Graham J. Belsham
Alexander Underwood
Anni Assing Winckelmann

Frontiers in Microbiology

doi 10.3389/fmicb.2021.698944

10,645 views
50 citations

Original Research

Published on 02 Sep 2020

Efficacy and Safety of Generic Sofosbuvir Plus Daclatasvir and Sofosbuvir/Velpatasvir in HCV Genotype 3-Infected Patients: Real-World Outcomes From Pakistan

in Drugs Outcomes Research and Policies

Saima Mushtaq
Tayyab Saeed Akhter
Amjad Khan
Aamir Sohail
Arshad Khan
Sobia Manzoor

Frontiers in Pharmacology

doi 10.3389/fphar.2020.550205

12,018 views
20 citations

Original Research

Published on 21 Sep 2023

Hepatitis C virus alters the morphology and function of peroxisomes

in Virology

Esther Martin de Fourchambault
Nathalie Callens
Jean-Michel Saliou
Marie Fourcot
Oceane Delos
Nicolas Barois
Quentin Thorel
Santseharay Ramirez
Jens Bukh
Laurence Cocquerel

Frontiers in Microbiology

doi 10.3389/fmicb.2023.1254728

7,912 views
12 citations

Articles

T cell receptor usage and epitope specificity amongst CD8+ and CD4+ SARS-CoV-2-specific T cells

GFTrans: An On-the-fly Static Analysis Framework for Code Performance Profiling

Hypervariable Region 1 in Envelope Protein 2 of Hepatitis C Virus: A Linchpin in Neutralizing Antibody Evasion and Viral Entry

Neutralizing antibody and CD8+ T cell responses following BA.4/5 bivalent COVID-19 booster vaccination in adults with and without prior exposure to SARS-CoV-2

Cure of chronic hepatitis C virus infection after DAA treatment only partially restores the functional capacity of exhausted T cell subsets: a systematic review

SARS-CoV-2 spike HexaPro formulated in aluminium hydroxide and administered in an accelerated vaccination schedule partially protects Syrian Hamsters against viral challenge despite low neutralizing antibody responses

In vitro Characterization of Fitness and Convalescent Antibody Neutralization of SARS-CoV-2 Cluster 5 Variant Emerging in Mink at Danish Farms

Efficacy and Safety of Generic Sofosbuvir Plus Daclatasvir and Sofosbuvir/Velpatasvir in HCV Genotype 3-Infected Patients: Real-World Outcomes From Pakistan

Hepatitis C virus alters the morphology and function of peroxisomes